Epic Sciences Expands Leadership Team to Address Liquid Biopsy Demand
/PRNewswire/ -- Epic Sciences, Inc, developer of novel diagnostics to personalize and advance the treatment and management of cancer, today announced the...
Stay updated with breaking news from Epic Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Epic Sciences, Inc, developer of novel diagnostics to personalize and advance the treatment and management of cancer, today announced the...
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $456.4 million for the third quarter ended September...
Cancer is not an easy target. It consists of a disease spectrum that ranges from high lethality that is spreading rapidly to locally confined malignancies without lethality over the average lifespan.
/PRNewswire/ -- The "Whole Genome And Exome Sequencing Markets" report has been added to ResearchAndMarkets.com's offering. Will all newborns receive Whole...
/PRNewswire/ -- The global circulating tumor cells market size is expected to reach USD 18.3 billion by 2027, according to a new report by Grand View Research,...